Term ends Feb 3, 2036 · High confidence
20-year base term ends Feb 3, 2036
Held by Amryt Pharmaceuticals Inc.
Filed May 22, 2020 as application 16/881,348 · Granted Jul 6, 2021
Base term, 20 years from filing
Today
2016
2036
Clock starts
Feb 3, 2016
Feb 3, 2016
Term ends
Feb 3, 2036
Feb 3, 2036
Granted
Jul 6, 2021
Jul 6, 2021
base term
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 3, 2016, when application 15/014,634, the earliest non-provisional in its chain, was filed (this one was filed May 22, 2020) | Feb 3, 2036 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 3, 2036 | High confidence |
This family
| US 10,238,709 | In force Feb 2036 | Feb 2036 |
| US 10,695,397 | In force no later than Feb 2036 | no later than Feb 2036 |
| US 11,052,126 | this patent Feb 2036 | Feb 2036 |
| US 11,338,011 | In force Feb 2036 | Feb 2036 |
| US 11,857,595 | In force Feb 2036 | Feb 2036 |
| US 11,510,963 | In force Feb 2036 | Feb 2036 |
| Application 18/514,644 | Abandoned not computed | not computed |
| US 12,251,418 | In force Feb 2036 | Feb 2036 |
8 of 9 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 28, 2021 Reel 56383, frame 364 | Mamluk, Roni | Chiasma, Inc. | Assignment of Assignor's Interest |
| May 28, 2021 Reel 56383, frame 400 | Teichman, Sam L. | Chiasma, Inc. | Assignment of Assignor's Interest |
| Jan 24, 2022 Reel 58739, frame 949 | Chiasma, Inc. | Amryt Endo, Inc. | Merger |
| Feb 18, 2022 Reel 59048, frame 944 | Amryt Endo, Inc. | Ares Capital Corporation, As Administrative Agent | Security Interest |
| Apr 13, 2023 Reel 63318, frame 849 | Ares Capital Corporation, As Administrative Agent | Amryt Pharmaceuticals, Inc.; Amryt Endo, Inc.; Amryt Research Limited; Amryt Genetics Limited | Release of Security Interest |
| Apr 13, 2023 reel/frame not recorded | Ares Capital Corporation, As Administrative Agent | Amryt Pharmaceuticals, Inc. | Release of Security Interest |
| Apr 13, 2023 reel/frame not recorded | Ares Capital Corporation, As Administrative Agent | Amryt Endo, Inc. | Release of Security Interest |
| Apr 13, 2023 reel/frame not recorded | Ares Capital Corporation, As Administrative Agent | Amryt Research Limited | Release of Security Interest |
| Apr 13, 2023 reel/frame not recorded | Ares Capital Corporation, As Administrative Agent | Amryt Genetics Limited | Release of Security Interest |
| Mar 19, 2024 Reel 66833, frame 786 | McEvoy, John | Amryt Endo, Inc. | Change of Address |
| Jan 7, 2026 Reel 73389, frame 551 | Amryt Endo, Inc.; Amyrt Pharmaceuticals Inc. | Amryt Pharmaceuticals Inc. | Merger and Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Feb 2036
Term ends Feb 3, 2036. Maintenance fees still fall due before then
Citations
13
later US patents cite this one
That is top 25% of utility patents granted in 2021 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.